Patents by Inventor Arvind JAYAN

Arvind JAYAN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS AND METHODS FOR TREATING MYELOFIBROSIS
    Publication number: 20210244735
    Abstract: Provided herein are compositions and methods for treating myelofibrosis in a subject. The methods comprise administering to the subject an effective amount of compound which is which is N-tert-butyl-3-[(5-methyl-2-{[4-(2-pyrrolidin-1-ylethoxy)phenyl]amino}pyrimidin-4-yl)amino]benzenesulfonamide or a pharmaceutical salt thereof or a hydrate thereof.
    Type: Application
    Filed: April 1, 2021
    Publication date: August 12, 2021
    Inventors: Arvind Jayan, Janice Cacace
  • COMPOSITIONS AND METHODS FOR TREATING MYELOFIBROSIS
    Publication number: 20190381041
    Abstract: Provided herein are compositions and methods for treating myelofibrosis in a subject. The methods comprise administering to the subject an effective amount of compound which is which is N-tert-butyl-3-[(5-methyl-2-{[4-(2-pyrrolidin-1-ylethoxy)phenyl]amino}pyrimidin-4-yl)amino]benzenesulfonamide or a pharmaceutical salt thereof or a hydrate thereof.
    Type: Application
    Filed: August 23, 2019
    Publication date: December 19, 2019
    Inventors: Arvind Jayan, Janice Cacace
  • Compositions and methods for treating myelofibrosis
    Patent number: 10391094
    Abstract: Provided herein are compositions and methods for treating myelofibrosis in a subject. The methods comprise administering to the subject an effective amount of compound which is which is N-tert-butyl-3-[(5-methyl-2-{[4-(2-pyrrolidin-1-ylethoxy)phenyl]amino}pyrimidin-4-yl)amino]benzenesulfonamide or a pharmaceutical salt thereof or a hydrate thereof.
    Type: Grant
    Filed: May 6, 2013
    Date of Patent: August 27, 2019
    Assignee: Impact Biomedicines, Inc.
    Inventors: Arvind Jayan, Janice Cacace
  • COMPOSITIONS AND METHODS FOR TREATING MYELOFIBROSIS
    Publication number: 20130252988
    Abstract: Provided herein are compositions and methods for treating myelofibrosis in a subject. The methods comprise administering to the subject an effective amount of compound which is which is N-tert-butyl-3-[(5-methyl-2-{[4-(2-pyrrolidin-1-ylethoxy)phenyl]amino}pyrimidin-4-yl)amino]benzenesulfonamide or a pharmaceutical salt thereof or a hydrate thereof.
    Type: Application
    Filed: May 6, 2013
    Publication date: September 26, 2013
    Applicant: TARGEGEN, INC.
    Inventors: Arvind JAYAN, Janice CACACE, Ayalew TEFFERI
  • COMPOSITIONS AND METHODS FOR TREATING MYELOFIBROSIS
    Publication number: 20130243853
    Abstract: Provided herein are compositions and methods for treating myelofibrosis in a subject. The methods comprise administering to the subject an effective amount of compound which is which is N-tert-butyl-3-[(5-methyl-2-{[4-(2-pyrrolidin-1-ylethoxy)phenyl]amino}pyrimidin-4-yl)amino]benzenesulfonamide or a pharmaceutical salt thereof or a hydrate thereof.
    Type: Application
    Filed: May 6, 2013
    Publication date: September 19, 2013
    Applicant: TargeGen, Inc.
    Inventors: Arvind JAYAN, Janice CACACE, Ayalew TEFFERI